Biosimilar Agents for Psoriasis Treatment: The Perspective of Portuguese Patients.
CONCLUSION: Biosimilars may increase patient access to biologic therapies. Improved communication and the involvement of patients in decision-making regarding biosimilars may increase their acceptance in future.
PMID: 30332374 [PubMed - in process]
Source: Acta Medica Portuguesa - Category: General Medicine Tags: Acta Med Port Source Type: research
More News: Dermatology | Education | General Medicine | Healthcare Costs | Portugal Health | Psoriasis | Skin | Study | Universities & Medical Training